Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Aposense Ltd..
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Aposense Ltd.
ClinicalTrials.gov Identifier:
NCT00805636
First received: December 7, 2008
Last updated: May 11, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2010
  Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)